New Parkinson's drug candidate enters early human safety trials
NCT ID NCT06565195
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 35 times
Summary
This early-stage study tests a new drug called LY3962681 for safety and how the body processes it. First, healthy volunteers get a single dose into their spinal fluid. Then, people with Parkinson's disease get two doses, spaced months apart. The goal is to see if the drug is safe and to measure its effects on Parkinson's-related proteins.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Austin Clinic PPD
RECRUITINGAustin, Texas, 78744-1625, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ehime University Hospital
NOT_YET_RECRUITINGTōon, Ehime, 791-0295, Japan
-
Oita University Hospital
NOT_YET_RECRUITINGYufu, Oita Prefecture, 879-5593, Japan
-
P-One Clinic, Keikokai Medical Corporation
RECRUITINGHachiōji, Tokyo, 192-0071, Japan
Conditions
Explore the condition pages connected to this study.